JNJ
Johnson & Johnson
NEW YORK STOCK EXCHANGE, INC.· Pharmaceuticals· US· IPO 1944-09-25
$275.21
+4.02 (+1.48%)
last quote
Want the full multi-source brief on JNJ?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$275.21
High
$281.07
Low
$273.53
Previous close
$271.19
Fundamentals
Market cap
$629.71B
P/E (TTM)
29.93x
P/S (TTM)
6.43x
P/B
6.13x
Gross margin
68.05%
Operating margin
25.73%
Net margin
21.48%
Rev growth (YoY)
8.06%
EPS growth (YoY)
-7.75%
ROE
25.74%
52W high
$281.07
52W low
$173.33
Beta
0.21x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-10-13in 39 days
Q3 2026EPS est $2.95Rev est $25572.4M
Recent SEC filings
CIK 200406filing-language history →
Recent news
2026-08-27 → 2026-09-03
Yahoo · 9h
Amgen Stock Signals Its Confidence. The Market Agrees.
The real bet is on what lies beyond this year's performance: a pipeline that could change everything.
Yahoo · 9h
Sector Update: Healthcare Stocks Advance Late Afternoon
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index and the State
Yahoo · 9h
ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.
ChartMill · 11h
Discover which dow jones stocks are making waves on Wednesday.
Get insights into the dow jones index performance on Wednesday. Explore the top gainers and losers within the dow jones index in today's session.
Yahoo · 11h
The Wide Divide Priced Into Boston Scientific Stock
The market's valuation reflects a wide breadth of potential outcomes for the company, exposing shareholders to the full magnitude of that underlying risk.
Yahoo · 11h
Sector Update: Healthcare Stocks Advance Wednesday Afternoon
Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index adding 0.7% and th
Yahoo · 11h
How Did Merck Stock Beat The Market With Slowing Sales?
Before the eighty-five percent surge, the company's pipeline story was getting louder just as its revenue trajectory was getting quieter.
Yahoo · 12h
J&J Jumps as UBS Lifts Its Target to $320
The new objective implies roughly 16% upside and reflects stronger expectations for J&J's pharmaceutical pipeline.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial